ibudilast has been researched along with Age-Related Memory Disorders in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Four experiments examined whether Ibudilast, a clinically approved neuroimmune therapy, would reduce tactile allodynia and memory impairments caused by oxaliplatin in laboratory rats." | 7.85 | Ibudilast reduces oxaliplatin-induced tactile allodynia and cognitive impairments in rats. ( Cao, J; Fardell, JE; Forrest, DRL; Hutchinson, MR; Johnston, IN; Matsos, A; Si, E; Tan, M, 2017) |
| "At 6 months after the start of ibudilast therapy, all patients reported the resolution of dizziness; of the 6 patients with depression at entry, all experienced significant improvement." | 7.74 | Effect of ibudilast on non-specific symptoms in patients with chronic cerebral ischemia. Analysis of cerebral blood flow. ( Harada, M; Inoue, N, 2008) |
| "Ibudilast is a multi-target drug, as it is a phosphodiesterase inhibitor and toll-like receptor 4 (TLR4) antagonist." | 5.91 | Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. ( Chaudry, O; Figueiredo-Pereira, ME; Liu, Q; Oliveros, G; Qiu, Y; Rockwell, P; Serrano, PA; Wallace, CH; Xie, L, 2023) |
| " Four experiments examined whether Ibudilast, a clinically approved neuroimmune therapy, would reduce tactile allodynia and memory impairments caused by oxaliplatin in laboratory rats." | 3.85 | Ibudilast reduces oxaliplatin-induced tactile allodynia and cognitive impairments in rats. ( Cao, J; Fardell, JE; Forrest, DRL; Hutchinson, MR; Johnston, IN; Matsos, A; Si, E; Tan, M, 2017) |
| "At 6 months after the start of ibudilast therapy, all patients reported the resolution of dizziness; of the 6 patients with depression at entry, all experienced significant improvement." | 3.74 | Effect of ibudilast on non-specific symptoms in patients with chronic cerebral ischemia. Analysis of cerebral blood flow. ( Harada, M; Inoue, N, 2008) |
| "Ibudilast is a multi-target drug, as it is a phosphodiesterase inhibitor and toll-like receptor 4 (TLR4) antagonist." | 1.91 | Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. ( Chaudry, O; Figueiredo-Pereira, ME; Liu, Q; Oliveros, G; Qiu, Y; Rockwell, P; Serrano, PA; Wallace, CH; Xie, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveros, G | 1 |
| Wallace, CH | 1 |
| Chaudry, O | 1 |
| Liu, Q | 1 |
| Qiu, Y | 1 |
| Xie, L | 1 |
| Rockwell, P | 1 |
| Figueiredo-Pereira, ME | 1 |
| Serrano, PA | 1 |
| Johnston, IN | 1 |
| Tan, M | 1 |
| Cao, J | 1 |
| Matsos, A | 1 |
| Forrest, DRL | 1 |
| Si, E | 1 |
| Fardell, JE | 1 |
| Hutchinson, MR | 1 |
| Wang, H | 1 |
| Mei, Zl | 1 |
| Zhong, KL | 1 |
| Hu, M | 1 |
| Long, Y | 1 |
| Miao, MX | 1 |
| Li, N | 1 |
| Yan, TH | 1 |
| Hong, H | 1 |
| Inoue, N | 1 |
| Harada, M | 1 |
4 other studies available for ibudilast and Age-Related Memory Disorders
| Article | Year |
|---|---|
Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Drug Repositioning; Femal | 2023 |
Ibudilast reduces oxaliplatin-induced tactile allodynia and cognitive impairments in rats.
Topics: Analgesics; Animals; Antineoplastic Agents; Cognitive Dysfunction; Conditioning, Psychological; Fear | 2017 |
Pretreatment with antiasthmatic drug ibudilast ameliorates Aβ 1-42-induced memory impairment and neurotoxicity in mice.
Topics: Amyloid beta-Peptides; Animals; Anti-Asthmatic Agents; Caspase 3; Cerebral Cortex; Hippocampus; Memo | 2014 |
Effect of ibudilast on non-specific symptoms in patients with chronic cerebral ischemia. Analysis of cerebral blood flow.
Topics: Aged; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Depression; Dizziness; Female; F | 2008 |